Cargando…
Evaluation of commercial kits for isolation and bisulfite conversion of circulating cell-free tumor DNA from blood
BACKGROUND: DNA methylation biomarkers in circulating cell-free DNA (cfDNA) have great clinical potential for cancer management. Most methods for DNA methylation analysis require bisulfite conversion, causing DNA degradation and loss. This is particularly challenging for cfDNA, which is naturally fr...
Autores principales: | Kresse, Stine H., Brandt-Winge, Sara, Pharo, Heidi, Flatin, Bjørnar T. B., Jeanmougin, Marine, Vedeld, Hege Marie, Lind, Guro E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503171/ https://www.ncbi.nlm.nih.gov/pubmed/37710283 http://dx.doi.org/10.1186/s13148-023-01563-0 |
Ejemplares similares
-
PoDCall: positive droplet calling and normalization of droplet digital PCR DNA methylation data
por: Jeanmougin, Marine, et al.
Publicado: (2022) -
Multiregional assessment of CIMP in primary colorectal cancers: Phenotype concordance but marker variability
por: Flatin, Bjørnar T.B., et al.
Publicado: (2020) -
Experimental factors affecting the robustness of DNA methylation analysis
por: Pharo, Heidi D., et al.
Publicado: (2016) -
Targeted genetic and epigenetic profiling of esophageal adenocarcinomas and non-dysplastic Barrett’s esophagus
por: Pinto, Rita, et al.
Publicado: (2022) -
BladMetrix: a novel urine DNA methylation test with high accuracy for detection of bladder cancer in hematuria patients
por: Pharo, Heidi Dietrichson, et al.
Publicado: (2022)